Davide Giusti, Elisabetta Colaci, Valeria Pioli, Federico Banchelli, Monica Maccaferri, Giovanna Leonardi, Roberto Marasca, Monica Morselli, Fabio Forghieri, Francesca Bettelli, Angela Cuoghi, Paola Bresciani, Andrea Messerotti, Andrea Gilioli, Anna Candoni, Luca Cassanelli, Elena Sbadili, Ilaria Bassoli, Giuseppe Longo, Fabio Gilioli, Eleonora Borelli, Sarah Bigi, Roberto D'Amico, Carlo Adolfo Porro, Oreofe Odejide, Camilla Zimmermann, Fabio Efficace, Eduardo Bruera, Mario Luppi, Elena Bandieri, Leonardo Potenza
OBJECTIVES: Although early palliative care (EPC) is beneficial in acute myeloid leukaemia, little is known about EPC value in multiple myeloma (MM). We compared quality indicators for palliative and end-of-life (EOL) care in patients with MM receiving EPC with those of patients who received usual haematological care (UHC). METHODS: This observational, retrospective study was based on 290 consecutive patients with MM. The following indicators were abstracted: providing psychological support, assessing/managing pain, discussing goals of care, promoting advance care plan, accessing home care services; no anti-MM treatment within 14 and 30 days and hospice length of stay >7 days before death; no cardiopulmonary resuscitation, no intubation, <2 hospitalisations and emergency department visits within 30 days before death...
September 26, 2023: BMJ Supportive & Palliative Care